PB Fourie
PB Fourie
Dept of Medical Microbiology, University of Pretoria, South Africa
Bekræftet mail på up.ac.za
Citeret af
Citeret af
Gatifloxacin for TB
R Rustomjee, C Lienhardt, T Kanyok, GR Davies, J Levin, T Mthiyane, ...
A phase II study of the sterilising activities of ofloxacin, gatifloxacin …, 2008
Clofazimine: current status and future prospects
MC Cholo, HC Steel, PB Fourie, WA Germishuizen, R Anderson
Journal of antimicrobial chemotherapy 67 (2), 290-298, 2012
The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis
B Blomberg, S Spinaci, B Fourie, R Laing
Respiratory tuberculosis in childhood: the diagnostic value of clinical features and special investigations.
HS Schaaf, N Beyers, RP Gie, ED Nel, NA Smuts, FE Scøtt, PR Donald, ...
The Pediatric infectious disease journal 14 (3), 189-194, 1995
Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa
WH Haas, K Schilke, J Brand, B Amthor, K Weyer, PB Fourie, G Bretzel, ...
Antimicrobial agents and chemotherapy 41 (7), 1601-1603, 1997
Inhaled drug therapy for treatment of tuberculosis
A Misra, AJ Hickey, C Rossi, G Borchard, H Terada, K Makino, PB Fourie, ...
Tuberculosis 91 (1), 71-81, 2011
Immunization by a bacterial aerosol
L Garcia-Contreras, YL Wong, P Muttil, D Padilla, J Sadoff, J DeRousse, ...
Proceedings of the National Academy of Sciences 105 (12), 4656-4660, 2008
Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model
L Garcia-Contreras, J Fiegel, MJ Telko, K Elbert, A Hawi, M Thomas, ...
Antimicrobial agents and chemotherapy 51 (8), 2830-2836, 2007
Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis Isolates
M Mphahlele, H Syre, H Valvatne, R Stavrum, T Mannsåker, T Muthivhi, ...
Journal of clinical microbiology 46 (10), 3459-3464, 2008
Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis.
MM McGregor, P Olliaro, L Wolmarans, B Mabuza, M Bredell, MK Felten, ...
American journal of respiratory and critical care medicine 154 (5), 1462-1467, 1996
The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis
FA Sirgel, PB Fourie, PR Donald, N Padayatchi, R Rustomjee, J Levin, ...
American journal of respiratory and critical care medicine 172 (1), 128-135, 2005
Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis
AS Dharmadhikari, M Kabadi, B Gerety, AJ Hickey, PB Fourie, E Nardell
Antimicrobial agents and chemotherapy 57 (6), 2613-2619, 2013
Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains
LT Daum, JD Rodriguez, SA Worthy, NA Ismail, SV Omar, AW Dreyer, ...
Journal of clinical microbiology 50 (12), 3831-3837, 2012
Procedures for developing a simple scoring method based on unsophisticated criteria for screening children for tuberculosis
PB Fourie, PJ Becker, F Festenstein, GB Migliori, J Alcaide, M Antunes, ...
The International Journal of Tuberculosis and Lung Disease 2 (2), 116-123, 1998
Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline
MC Cholo, MT Mothiba, B Fourie, R Anderson
Journal of Antimicrobial Chemotherapy, dkw426, 2016
Fixed-dose combination drugs for tuberculosis: application in standardised treatment regimens
B Blomberg, B Fourie
Drugs 63 (6), 535-553, 2003
Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market
G Pillai, PB Fourie, N Padayatchi, PC Onyebujoh, H McIlleron, PJ Smith, ...
The International Journal of Tuberculosis and Lung Disease 3 (11), S309-S316, 1999
Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption
GA Ellard, PB Fourie
The International Journal of Tuberculosis and Lung Disease 3 (11), S301-S308, 1999
Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial
Durban Immunotherapy Trial Group
The Lancet 354 (9173), 116-119, 1999
Activity of 7-methyljuglone derivatives against Mycobacterium tuberculosis and as subversive substrates for mycothiol disulfide reductase
A Mahapatra, SPN Mativandlela, B Binneman, PB Fourie, CJ Hamilton, ...
Bioorganic & medicinal chemistry 15 (24), 7638-7646, 2007
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20